Library
4-MeO-PCP
4-MeO-PCP is an arylcyclohexylamine synthetic dissociative that can produce hallucinogenic and anesthetic effects. First synthesized in 1965 by Parke-Davis chemist Victor Maddox, it became the first arylcyclohexylamine research chemical sold online when it appeared in late 2008. It is reported to have reduced potency relative to PCP. Dosage information remains tentative, potentially due to variations in the potency of available supplies.
Also known as: Methoxydine, 4-methoxy-pcp
Classification
- Chemical: Arylcyclohexylamine
- Psychoactive: Dissociative
- Tag: Habit-Forming
- Tag: Hallucinogen
- Tag: Research-Chemical
Effects
- Creativity Enhancement
- Tactile Disconnection
- Spontaneous Tactile Sensations
- Physical Euphoria
- Nausea
- Physical Disconnection
- Depersonalization
- Derealization
- Consciousness Disconnection
- Memory Suppression
- Ego Death
- Thought Deceleration
- Disinhibition
- Tactile Suppression
- Perception Of Decreased Weight
- Visual Sliding
- Hallucinations
- Environmental Cubism
Routes of Administration
Oral
Dosage
- Heavy: 250 mg
- Light: 25 – 75 mg
- Common: 75 – 150 mg
- Strong: 150 – 250 mg
- Threshold: 25-50 mg
Duration
- Onset: 0.75-2 h
- Comeup: 1-2 h
- Peak: 3-7 h
- Offset: 6-10 h
- After Effects: 6-12 h
Insufflated
Dosage
- Heavy: 150 mg
- Light: 15 – 75 mg
- Common: 75 – 125 mg
- Strong: 125 – 150 mg
- Threshold: 15 mg
Duration
- Onset: 0.1-0.2 h
- Comeup: 0.25-0.5 h
- Peak: 3-6 h
- Offset: 3 h
- After Effects: 3 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
